"Johnson & Johnson has raised its quarterly dividend from $0.46 per share in 2008 to $1.34 per share today, a trajectory that reflects consistent free cash flow generation and a management team that treats dividend growth as a core obligation to shareholders."
"At a current yield of 3.2%, Johnson & Johnson offers income investors a return that exceeds the healthcare sector average of 1.8% by a meaningful margin."
"CEO Joaquin Duato framed the broader momentum clearly in the Q1 2026 earnings release: 'Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact.'"
Johnson & Johnson announced a 3% increase in its quarterly dividend, raising it from $1.30 to $1.34 per share. This marks the company's 64th consecutive annual dividend increase, reflecting a strong commitment to shareholders. The current yield of 3.2% significantly exceeds the healthcare sector average of 1.8%. The company has demonstrated consistent free cash flow generation, with $1.5 billion reported in Q1 2026, supporting its dividend growth strategy and reinforcing its disciplined financial management.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]